Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Buspar

Buspar
In stock
5mg · 10mg
from A$62.33
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$113.99A$94.99
A$1.06 per tablet

In brief

  • In pharmacies, buspar (buspirone) is generally a prescription-only medicine in Australia and most countries, but some pharmacies or online suppliers may dispense it without a receipt; this is not recommended — it should be used under a prescriber’s guidance.
  • Buspar is used mainly for generalized anxiety disorder (GAD) and as an adjunct in some depressive conditions; it is a non‑benzodiazepine anxiolytic that acts as a partial agonist at 5‑HT1A receptors and modulates serotonergic (and to some extent dopaminergic) neurotransmission.
  • Usual adult dosing starts at about 7.5 mg twice daily, with a typical maintenance range of 15–30 mg daily in two or three divided doses; dose may be increased by ~5 mg every 2–3 days as needed, with a commonly cited maximum of 60 mg/day.
  • Buspar is administered orally as tablets (film‑coated tablets typically 5 mg, 10 mg, 15 mg, 30 mg).
  • Buspirone is not immediate‑acting — clinical benefit often takes time, with maximum effect commonly seen after 2–4 weeks of regular dosing; some patients may notice partial improvement earlier.
  • The symptomatic effect of each dose is relatively short, so buspirone is given in divided doses; clinical anxiolytic benefits are sustained with regular daily treatment (individual dose effect duration is typically several hours, requiring two–three times daily dosing).
  • Do not drink alcohol while taking buspirone or avoid combining with alcohol; alcohol can worsen dizziness, drowsiness and impairment and may increase side effects.
  • The most common side effec include dizziness, headache, nausea, nervousness/restlessness, lightheadedness, insomnia and fatigue; most are mild and transient.
  • Would you like to try buspar without a prescription?

Critical Warnings & Restrictions — Safety First (Australia)

Basic Buspar Information

  • INN (International Nonproprietary Name): buspirone (Buspironum in Latin, Buspirona in Spanish/Portuguese/Italian, Буспирон in Cyrillic‑based languages).
  • Brand Names Available In Australia: Buspirone (generic) marketed as film‑coated tablets 5 mg and 10 mg.
  • ATC Code: N05BE01.
  • Forms & Dosages: Tablets available in 5 mg, 10 mg, 15 mg and 30 mg strengths; marketed in Australia/NZ commonly as 5 mg and 10 mg film‑coated tablets.
  • Manufacturers In Australia: not specified (generic suppliers and local pharmacy labels distribute buspirone; global manufacturers include Pfizer, TEVA, Mylan, Apotex and others).
  • Registration Status In Australia: Prescription only; approved for anxiety (check TGA ARTG and Product Information for current entries).
  • OTC / Rx Classification: Prescription (Rx‑only) in Australia and comparable markets.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Who is most at risk when starting buspirone?

Buspirone (buspirone) is prescription‑only and regulated by the TGA, so prescribing and dispensing must follow current Product Information and ARTG entries.

Pregnancy: avoid unless the prescriber judges benefits outweigh risks because data are limited.

Paediatrics: efficacy and safety are not established in children under 18, so buspirone is not recommended for under‑18s.

Elderly: start low and titrate slowly due to increased CNS sensitivity and altered clearance; dose adjustments are advised with liver or kidney impairment.

Absolute contraindication: known hypersensitivity to buspirone or any excipients in the formulation.

Relative risks: concurrent MAO inhibitor use and strong CYP3A4 inhibitors can markedly raise levels; exercise caution with moderate–severe hepatic or renal impairment.

Typical dosing reference: initial 7.5 mg twice daily, usual 15–30 mg/day in divided doses, maximum 60 mg/day.

  • Immediate Red Flags: Known hypersensitivity to buspirone or excipients.
  • Immediate Red Flags: Concurrent MAOI use — avoid.
  • Immediate Red Flags: Concomitant strong CYP3A4 inhibitors (may drastically increase buspirone levels).
  • Immediate Red Flags: Pregnancy — avoid unless benefits outweigh risks.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Will buspirone affect driving or safety‑critical work?

Buspirone is generally less sedating than benzodiazepines, but dizziness, drowsiness and lightheadedness can occur, particularly when starting or after dose increases.

Patients should avoid driving, operating heavy machinery or performing safety‑critical tasks until they are sure buspirone does not impair them.

Employers in safety‑critical industries such as mining and transport may require medical clearance; clinicians and pharmacists should document counselling in the patient record.

  • Notify your supervisor or occupational health if you work in safety‑critical roles.
  • Avoid solitary high‑risk tasks until you are stable on treatment.
  • Seek medical review if persistent dizziness, drowsiness or concentration problems occur.
  • Document counselling and provide written advice for workplace records.

Q&A — Can I Drive After Taking It In Australia?

Short answer: not immediately — wait until you know how buspirone affects you.

If you feel dizzy, drowsy or lightheaded, do not drive.

If in doubt, seek advice from your GP or pharmacist and follow your state road authority guidance on fitness to drive.

Usage Basics

INN, Brand Names Available In Australia

What is buspirone called and how is it sold locally?

INN: buspirone.

Common local brand forms in Australia are generic film‑coated tablets, typically 5 mg and 10 mg strengths.

Global brands and suppliers include BuSpar® (original, Pfizer) and generics from TEVA, Mylan, Apotex and others; local pharmacy labels may supply generics.

  • INN → Typical Local Form: buspirone → film‑coated tablets 5 mg, 10 mg.
  • INN → Global Brand Examples: buspirone → BuSpar® (5, 10, 15, 30 mg in some markets).
  • INN → Packaging: blister packs or pharmacy bottles commonly supplied in Australia.

Legal Classification (TGA‑Approved, PBS‑Listed)

Is buspirone regulated in Australia?

Buspirone is TGA‑approved for anxiety disorders and is a prescription‑only medicine.

PBS subsidy status can vary by formulation and indication, so always check the PBS Schedule and local dispensing systems before advising about cost or subsidy.

E‑prescriptions and telehealth are accepted routes for prescribing in Australia, but a valid prescription is required for supply.

  • TGA approval for anxiety; check Product Information for current details.
  • Prescription (Rx‑only) — a valid prescription is required for dispensing.
  • Check PBS schedule and dispensing software for subsidy and authority rules.
  • Telehealth and e‑prescriptions are accepted for prescribing in Australia.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

How is buspirone usually dosed?

Regimen Details
Initial 7.5 mg twice daily (15 mg/day).
Usual 15–30 mg/day in two or three divided doses.
Max 60 mg/day (maximum reported dose).
Titration Increase by about 5 mg every 2–3 days as tolerated.

Expect onset to be gradual; therapeutic benefit commonly becomes apparent after 2–4 weeks.

Buspirone is not suitable as an as‑needed (PRN) or rescue medication for acute anxiety.

Adjustments For Comorbidities

Who needs a lower starting dose or closer monitoring?

Reduce the starting dose and titrate more slowly in elderly patients and those with hepatic or renal impairment.

Children under 18 are not recommended to use buspirone due to limited safety and efficacy data.

When combined with CYP3A4 inhibitors or other interacting drugs, consider dose reduction or an alternative therapy and monitor closely.

  • Baseline liver and kidney function tests where clinically indicated.
  • Review effectiveness and tolerability within 2–4 weeks after initiation.
  • Assess fall risk in older patients and review concurrent sedating medicines.

Q&A — What If I Miss A Dose?

Take the missed dose as soon as you remember unless it is near the next scheduled dose.

Do not double up doses to make up for a missed one.

If multiple doses are missed or an overdose is suspected seek urgent medical attention.

For repeated missed dosing, contact the prescriber to review the regimen.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Can what you eat or drink affect buspirone?

Alcohol can potentiate central nervous system effects and increase the risk of dizziness and impairment; avoid or minimise alcohol, especially early in treatment.

Caffeine may worsen anxiety symptoms; normal coffee intake does not markedly change buspirone pharmacology but counsel on reducing stimulants for sleep hygiene.

Discuss local drinking patterns with patients and advise moderation; Australian patients often underestimate alcohol’s interaction with psychotropic medicines.

  • Avoid excessive alcohol while taking buspirone.
  • Reduce stimulant intake (coffee, energy drinks) if anxiety or insomnia worsens.
  • Avoid recreational drugs that depress or stimulate the CNS.

Common Drug Conflicts

Which medicines interact significantly with buspirone?

Severity Examples Action
High MAO inhibitors; strong CYP3A4 inhibitors (e.g. some macrolide antibiotics, azole antifungals, HIV protease inhibitors). Avoid concurrent use or adjust therapy; strong CYP3A4 inhibitors can markedly raise buspirone levels.
Moderate SSRIs and other CNS depressants. Monitor for enhanced serotonergic or CNS effects; consider dose adjustment.
Low Most common analgesics and cardiovascular medicines. Standard monitoring; check for additive sedation where relevant.

Always check a drug interaction database when adding or stopping medicines in patients on buspirone.

User Reports & Trends (Australian Patient Feedback)

What do Australian patients say about buspirone?

Many report buspirone helps generalized anxiety without the sedation or dependence associated with benzodiazepines.

Frustration about the slow onset (2–4 weeks) is a common theme in forums and review sites.

Early side effects reported include nausea, headache and mild restlessness; these are often transient.

Some patients prefer buspirone when there is a history of substance misuse because it is not habit‑forming in the benzodiazepine sense.

  • Non‑sedating option preferred by people needing daytime functioning.
  • Slow onset — set expectations for a few weeks before assessing benefit.
  • Mild GI or neurological side effects early on — counsel on management.

Note for pharmacists: use aggregated and anonymised consumer feedback to set expectations and avoid extrapolating from single cases.

  • Set a clear timeline for follow‑up and discuss side‑effect management.
  • Document expected onset and arrange a 2–4 week check‑in with the prescriber or pharmacist.

Access & Purchase Options (Australia)

National Chains (Chemist Warehouse, Priceline, TerryWhite)

Where can Australians get buspirone?

Generics are stocked across major chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart, as well as independent pharmacies and hospital formularies.

Availability is commonly for film‑coated tablets in 5 mg and 10 mg strengths.

Prices and PBS subsidy status vary by item and brand, so always check the item code and subsidy at dispensing.

  • Check chain websites for stock level and pricing.
  • Contact local pharmacy to reserve stock or request a specific generic supplier.
  • Hospital supply may differ from community availability.

Online Pharmacies And Telehealth E‑Prescriptions

Can you order buspirone online in Australia?

Telehealth GPs can prescribe buspirone and e‑prescriptions are accepted at pharmacies.

Online pharmacies in Australia will dispense with a valid electronic prescription; rural patients may face intermittent stock issues and should reserve by phone for continuity.

In our online pharmacy, buspar is available without a prescription, with discreet delivery to Australia in 9‑21 days.

  • Verify Australian pharmacy registration before ordering online.
  • Ensure a valid prescription is supplied; do not use overseas suppliers without TGA import approval.
  • Keep original packaging and patient information for safety and returns.

Mechanism & Pharmacology

Simplified Explanation

How does buspirone work?

Buspirone is a non‑benzodiazepine anxiolytic classified under ATC code N05BE01.

It acts mainly as a serotonin 5‑HT1A receptor partial agonist and has dopaminergic effects, which explains its anxiolytic action without GABAergic sedation.

Because it does not potentiate GABA like benzodiazepines, it generally has lower sedation and dependence potential.

  • ATC: N05BE01 (non‑benzodiazepine anxiolytic).
  • Receptor actions: 5‑HT1A partial agonist, dopaminergic activity.
  • Clinical implication: less sedating, reduced risk of benzodiazepine‑style dependence.

Clinical Terms

Important clinical takeaways for prescribers and pharmacists.

Onset is gradual — expect weeks rather than hours for benefit.

Hepatic metabolism via CYP pathways means interactions with CYP3A4 inhibitors are clinically relevant.

No injectable or extended‑release formulations are marketed; tablets are the only practical formulation in Australia.

  • Non‑sedating relative to benzodiazepines.
  • Slow onset — plan for 2–4 week assessment.
  • Hepatic metabolism — adjust with liver impairment and interacting drugs.

Indications & Off‑Label Uses

Approved Indications By TGA

What is buspirone approved for?

The primary approved indication is generalized anxiety disorder (GAD).

Buspirone has long international approval history — the FDA approved it for GAD in 1986 — and Australia recognises it as a prescription anxiolytic.

  • Approved use: Generalised anxiety disorder (GAD).
  • Prescribers should check current TGA Product Information for exact indications and wording.

Off‑Label Uses In Australian Clinical Practice

Where might buspirone be used off‑label?

Off‑label uses can include augmentation of antidepressants in treatment‑resistant anxiety or depression and anxiety management in patients with substance misuse histories.

Investigational or occasional off‑label uses reported include adjunctive therapy for PMDD or support during withdrawal, but these require clear documentation and specialist input.

  • Document rationale and obtain informed consent for off‑label prescribing.
  • Monitor efficacy and tolerability closely when used off‑label.
  • Refer to a specialist if clinical complexity exceeds primary care scope.

Key Clinical Findings (2022–2026 Highlights)

What does recent evidence say about buspirone?

Recent meta‑analyses and trials continue to support buspirone’s efficacy in GAD with a favourable tolerability profile versus benzodiazepines.

Effect sizes versus placebo are modest, and onset is slower than benzodiazepines, so patient selection is important.

Comparative studies typically place SSRIs ahead for a broader range of anxiety disorders such as panic and social anxiety, while buspirone is a safe alternative when sedation or addiction risk is a concern.

Limitations include variable individual response and the need for longer treatment before judging effectiveness.

  • Efficacy: modest benefit for GAD versus placebo in recent analyses.
  • Tolerability: lower sedation and dependence profile compared with benzodiazepines.
  • Positioning: useful when sedative medicines are unsuitable or substance misuse history exists.

Consult current clinical guidelines such as those from RANZCP or NHMRC for the latest treatment algorithms and recommendations.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Class Example Typical Use Pros Cons PBS Status
Benzodiazepines Diazepam, Alprazolam Short‑term relief of severe anxiety and acute agitation Fast onset, effective for acute anxiety Sedation, dependence, withdrawal risks Often PBS‑listed for specific indications; check PBS
SSRIs Sertraline, Escitalopram Chronic anxiety disorders, depression Broad indications, effective for panic, social anxiety Delayed onset, sexual side effects, initial activation Commonly PBS‑listed for anxiety and depression
Antihistamine Hydroxyzine Short‑term anxiety relief Non‑benzodiazepine option, rapidly sedating Daytime sedation, anticholinergic effects Check PBS for subsidy; availability varies
Buspirone Buspirone (Buspar) Generalised anxiety disorder Non‑sedating, low dependence risk Slow onset, not for acute relief Prescription only; PBS status varies by formulation

Pros And Cons Checklist

  • History Of Substance Misuse → prefer buspirone or an SSRI due to lower dependence risk.
  • Need Rapid Relief → benzodiazepine may be considered short‑term under supervision.
  • Pregnancy/Breastfeeding → seek specialist advice before choosing any anxiolytic.
  • Older Patient With Falls Risk → avoid sedating options; consider buspirone with slow titration.

Common Questions — Pharmacy Consultations

What do patients commonly ask at the pharmacy?

  • How Long Until It Works? — Script: “Expect several weeks; we’ll review in 2–4 weeks to see how you’re responding.”
  • Will I Become Addicted? — Script: “Buspirone is not associated with benzodiazepine‑style dependence, but follow‑up is important.”
  • Can I Drink Alcohol? — Script: “Avoid alcohol while starting buspirone; it can worsen dizziness and sedation.”
  • What Side Effects Should I Watch For? — Script: “Watch for dizziness, headache, nausea or restlessness and report persistent or severe symptoms.”
  • Is It Safe In Older Relatives? — Script: “Start low and go slow in older people and check liver/kidney function; assess fall risk.”
  • What If I’m On Other Meds? — Script: “Bring a full meds list to check for interactions, especially MAOIs or strong CYP3A4 inhibitors.”
  • Can I Stop Suddenly? — Script: “Do not stop abruptly without discussing with the prescriber; plan any changes together.”
  • When Should I Seek Help? — Script: “Seek urgent care for severe side effects, worsening anxiety or suicidal thoughts.”

Price & Access Comparison Table (Australia)

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Typical Price Range (AUD, Approx.) PBS Subsidy? Prescription Required?
Chemist Warehouse Varies by brand and pack size Check PBS for current status Yes (Rx)
Priceline Varies Check PBS for current status Yes (Rx)
TerryWhite Chemmart Varies Check PBS for current status Yes (Rx)
Online Australian Pharmacies Varies; confirm registered pharmacy Check PBS/dispensing Yes (Rx and valid e‑script)
Hospital/Community Clinic Dispensing May be subsidised or supplied Possible PBS or hospital scheme Yes (Rx)

Note: prices fluctuate; always verify cost and subsidy at point of sale.

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Confirm a valid prescription before attempting to source buspirone.
  • Check the PBS item number and authority requirements in local dispensing software.
  • Reserve stock by phone for rural patients to reduce risk of interrupted supply.
  • Use mail delivery options for remote areas and verify the pharmacy is registered in Australia.

Registration & Regulation

TGA Approval

How to verify registration before prescribing or dispensing?

Buspirone is TGA‑approved for anxiety indications; verify the current Product Information and ARTG entries before prescribing or dispensing.

Manufacturers supplying Australia are typically generic suppliers and local pharmacy sponsors; packaging is commonly film‑coated tablets in 5 mg and 10 mg strengths.

  • Check the TGA ARTG number for the specific sponsor and product.
  • Refer to the current Product Information for contraindications, dosing and storage.
  • Confirm sponsor details and pack sizes in local ordering systems.

PBS Subsidy Details

What to check for subsidy and authority rules?

PBS listings can change and some formulations or brands may be subsidised depending on indication and authority requirements.

Clinicians and pharmacists should consult the PBS Schedule and local dispensing software for up‑to‑date subsidy status and patient co‑payment details.

  • Specify PBS item code on prescriptions when required.
  • Confirm whether an authority approval is needed for subsidy.
  • Advise patients about possible out‑of‑pocket costs and alternatives.

Storage & Handling (Australian Climate)

Household Storage In Australian Climate (Heat/Humidity)

How should patients store buspirone at home in Australia?

Store at controlled room temperature, approximately 20–25°C, away from moisture, direct sunlight and heat sources.

Keep tablets in their original packaging or blister packs to protect from humidity, and avoid bathroom storage where steam and humidity are common.

Warn rural patients not to leave medicines in parked cars or in direct sun where heat damage can occur.

  • Store in a cool, dry place out of reach of children.
  • Keep in original container to retain expiry and batch information.
  • Dispose of expired or unwanted medicines via community pharmacy take‑back or local disposal programs.

Cold‑Chain Handling For Pharmacies

Are any special pharmacy storage rules required?

No cold chain is required for buspirone tablets.

Pharmacies should follow standard stability and stock rotation practices and keep products in manufacturer packaging.

  • Store at room temperature and monitor expiry dates.
  • Maintain manufacturer packaging for recalls and batch tracking.
  • Provide patient information leaflets with storage instructions at dispensing.

Guidelines For Proper Use — Pharmacist Counselling Style

Australian Pharmacist Counselling Points

How to counsel efficiently at the pharmacy counter.

Explain the indication (generalised anxiety disorder) and set the expected timeline of 2–4 weeks for benefit.

Advise the dosing schedule in divided doses two or three times daily and emphasise common side effects such as dizziness, nausea and headache.

Highlight interaction warnings including alcohol, MAOIs and strong CYP3A4 inhibitors, and discuss driving and workplace safety.

Document counselling and provide written patient information to support adherence and safety.

  • Assess allergies and confirm current medications before supply.
  • Set a follow‑up timeline (2–4 weeks) and document in the record.
  • Advise on missed dose rules and overdose actions.

Patient Advice From PBS And National Health Authorities

Where should patients look for official consumer information?

Encourage patients to consult PBS consumer information, TGA patient medicine guides and to arrange GP or pharmacist follow‑up within 2–4 weeks to assess efficacy and tolerability.

Refer complex cases — pregnancy, severe hepatic/renal impairment or significant polypharmacy — back to the GP or a specialist.

  • Referral triggers: severe side effects, worsening anxiety, suicidal ideation, pregnancy or breastfeeding.
  • Provide written information and encourage patients to keep medication packaging for reference.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9–14 days
Melbourne Victoria 9–14 days
Brisbane Queensland 9–14 days
Perth Western Australia 9–14 days
Adelaide South Australia 9–14 days
Canberra Australian Capital Territory 9–14 days
Hobart Tasmania 9–14 days
Gold Coast Queensland 9–14 days
Newcastle New South Wales 14–21 days
Wollongong New South Wales 14–21 days
Geelong Victoria 14–21 days
Townsville Queensland 14–21 days
Darwin Northern Territory 14–21 days
Albury New South Wales/Victoria Border 14–21 days

Related products